| Moderated By: Giuseppe Scalamogna -- (Not Moderated) -- Started: 7/12/1996 6:38:00 PM Revision History |
July 12, 1996
Cel-Sci corp announced that 78% of the SCID mice injected with blood of humans vaccinated with Cel-Sci's HGP-30 vaccine were protected against HIV challenge. This has proved to be a significant step in the progress of HGP-30's quest toward becoming the latest weapon in fighting HIV. Cel-Sci is a great company with an excellent research program showing excellent potential. I like it's prospects down the road as it also pursues methods of treating cancer. I think in light of the recent general sell-off in the market it is a good time to buy.